Results 171 to 180 of about 156,340 (338)

Recurrent Goiter, Hyperthyroidism, Galactorrhea and Amenorrhea due to a Thyrotropin ans Prolactin-Producing Pituitary Tumor [PDF]

, 1976
Erhardt, F., Fahlbusch, R., Horn, K., Pickardt, C. R., Scriba, Peter Christian, Werder, Klaus von   +5 more
core   +1 more source

Efficacy and safety of fruquintinib combined with albumin‐bound paclitaxel as second‐line therapy for advanced gastric cancer following failure of PD‐1 inhibitor‐containing treatment (TACTIC GC‐01): A phase II single‐arm study

International Journal of Cancer, Volume 158, Issue 9, Page 2219-2228, 1 May 2026.
What's new? Anti‐angiogenic drugs have shown promising efficacy as a second‐line treatment for advanced gastric cancer. However, it remains unclear how alterations in the tumor microenvironment following first‐line immunotherapy may impact tumor angiogenesis and influence subsequent therapeutic outcomes. This single‐arm study prospectively explored the
Xiaoting Ma, Kai Ou, Xiu Liu, Biyang Cao, Wenwei Yang, Jingyu Lu, Letian Zhang, Qi Wang, Lizhen Gao, Zhichao Jiang, Yongkun Sun, Lin Yang   +11 more
wiley   +1 more source

Integrative multi-omics analyses identify key genes and elucidate bidirectional regulatory mechanisms in thyroid dysfunction. [PDF]

PLoS One
Hu Y, Hu H, Xu L, Tang X, Wang C, Lian Z, Xie C, Xie Z, Wang Q.   +8 more
europepmc   +1 more source

External validation of the Ramathibodi paroxysmal supraventricular tachycardia recurrence score and development of a refined prediction model in a Hong Kong emergency department adult cohort: A retrospective study

Hong Kong Journal of Emergency Medicine, Volume 33, Issue 2, April 2026.
Abstract Background Paroxysmal supraventricular tachycardia (PSVT) recurrence after adenosine treatment is common in emergency departments (EDs), but predictive tools require validation. Objectives To externally validate the Ramathibodi PSVT recurrence score in a Hong Kong ED cohort and develop a refined local model for predicting 24‐h recurrence ...
Man Yu Chan
wiley   +1 more source

Coronary Artery Bypass Grafting in the Presence of Severe Hyperthyroidism: A Case Report. [PDF]

Am J Case Rep
Shimada A, Yamamoto T, Lee J, Dohi S, Endo D, Sato Y, Yokoyama Y, Tabata M.   +7 more
europepmc   +1 more source

Recurrent goiter and amenorrhea-galactorrhea Syndrome in a patient with a thyrotrophin- and prolactin-producing pituitary adenoma [PDF]

, 1975
Duncan, W. A., Fahlbusch, R., Hachmeister, U., Horn, K., Pickardt, C. R., Scriba, Peter Christian, Werder, Klaus von   +6 more
core   +2 more sources

Bariatric Surgery and Obstructive Sleep Apnea: Characteristics and Outcomes in a Pediatric Cohort

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 2, April 2026.
ABSTRACT Objectives The incidence of obstructive sleep apnea (OSA) and obesity is both increasing in adolescents. Bariatric surgery is well‐established for treating obesity in adolescents and is effective in treating obesity and other comorbid conditions.
A. Claire Chapel, Koshma Eswaramoorthy, Qunyh‐Chi Dang, Faisal Qureshi, Ron Mitchell, Anna Wani, Stephen Chorney, Yann‐Fuu Kou   +7 more
wiley   +1 more source

Non-autoimmune Familial Hyperthyroidism in Children: The Importance of Genetic Testing. [PDF]

Cureus
Sa Pinto M, Ferrão T, Dias Preda A, Moreno Fernandes M, Rangel MA.   +4 more
europepmc   +1 more source

Acute cardiovascular events and all-cause mortality in patients with hyperthyroidism: a population-based cohort study.

European Journal of Endocrinology, 2017
O. Dekkers, E. Horváth-Puhó, S. Cannegieter, J. Vandenbroucke, H. Sørensen, J. Jørgensen   +5 more
semanticscholar   +1 more source

Results and Exploratory Biomarker Analyses of a Phase II Study CHANGEABLE: Combination of PD‐1 Inhibitor and Niraparib in GErm‐Line‐mutAted Metastatic Breast Cancer

MedComm, Volume 7, Issue 4, April 2026.
This phase II trial evaluated the efficacy and safety of niraparib combined with HX008 in metastatic breast cancer (MBC) patients with germline DNA damage response (DDR) gene mutations. This chemotherapy‐free regimen demonstrates promising efficacy and a tolerable safety profile in MBC patients with germline DDR mutations, providing a novel therapeutic
Jian Zhang, Yiqun Du, Yanchun Meng, Yizi Jin, Mingxi Lin, Xuchen Shao, Xiaojun Liu, Yuxin Mu, Yun Liu, Zhen Hu   +9 more
wiley   +1 more source